Related Insights
Hormuz War‑Risk Premiums Hit 10% of Hull Value: Chemical Shipping Toll
When war‑risk insurance for vessels transiting the Strait of Hormuz surged to 10% of hull value, chemical shipping faced record freight rates and supply chain strain. This article examines the drivers, impacts, and strategic responses within Gulf maritime logistics.
Japan's Agrochemical Pivot Toward India: Following the Solar Materials Playbook
As Japanese chemical makers redirect investment from China to India across sectors like solar materials, agrochemical suppliers are watching whether a similar shift plays out in crop protection. For procurement teams managing fungicide, herbicide and insecticide portfolios, understanding whether this geographic pivot extends to agricultural chemicals matters for supply chain planning and sourcing strategy.
Sulfur and Aluminum Supply at Risk: What the Hormuz Crisis Means for Chemical Procurement
The Strait of Hormuz disruption extends beyond oil markets, affecting sulfur, aluminum, methanol and graphite that support global chemical manufacturing. Procurement teams should reassess sourcing strategies as industrial raw material risks continue to evolve.
Solstice‑Element Solutions Deal: How Logistics and Supply‑Chain Docs Will Shift
The recent Solstice acquisition of Element Solutions brings sweeping changes to chemical shipping documentation, emergency response protocols,hra regulatory compliance, and procurement processes. This article breaks down the implications for logistics professionals, supply‑chain managers, and legal teams navigating the ownership transition.
Sustainability and the Hormuz Crisis: Five Permanent Chemical Supply Chain Shifts for 2026 and Beyond
The 2026 Hormuz crisis has reshaped chemical logistics and sustainability metrics across global supply chains. From emissions accounting changes to sourcing diversification and ammonia project delays, procurement teams now face structural shifts that will persist beyond the immediate disruption.
Drug Shortage Risk Intelligence: June 24 Status Update
Drug shortage risk remains elevated in H2 2026 despite easing Hormuz tensions. Pharmaceutical procurement teams should prioritize safety stock updates, secondary supplier qualification, and stronger force majeure protections to secure supply continuity into 2027.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.